Range
1.65 - 1.72
Vol / Avg.
245.6K/1.1M
Div / Yield
-
52 Wk
1.25 - 8.59
Mkt Cap
132.4M
Payout Ratio
-
Open
1.66
P/E
-
EPS
-0.44
Shares
76.9M
Outstanding
76.9M
Total Float
74.4M
load more
Sector: Health Care.Industry: Biotechnology
Catabasis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company focuses on the discovery, development and commercialization of novel therapeutics.It develops products for the treatment of hereditary angioedema, or HAE, a rare, debilitating and potentially life-threatening disease. Its product candidate includes QLS-215.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CATBCatabasis Pharmaceuticals-4.07%132.4M

Catabasis Pharmaceuticals Frequently Asked Questions

Q

How do I buy Catabasis Pharmaceuticals (CATB) stock?

A

You can purchase shares of Catabasis Pharmaceuticals (NASDAQ: CATB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Catabasis Pharmaceuticals's (CATB) competitors?

Q

What is the target price for Catabasis Pharmaceuticals (CATB) stock?

A

The latest price target for Catabasis Pharmaceuticals (NASDAQ: CATB) was reported by Ladenburg Thalmann on May 12, 2021. The analyst firm set a price target for 6.00 expecting CATB to rise to within 12 months (a possible 248.84% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Catabasis Pharmaceuticals (CATB)?

A

The stock price for Catabasis Pharmaceuticals (NASDAQ: CATB) is $1.72 last updated Today at 8:00:01 PM.

Q

Does Catabasis Pharmaceuticals (CATB) pay a dividend?

A

There are no upcoming dividends for Catabasis Pharmaceuticals.

Q

When is Catabasis Pharmaceuticals (NASDAQ:CATB) reporting earnings?

A

Catabasis Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Catabasis Pharmaceuticals (CATB) going to split?

A

There is no upcoming split for Catabasis Pharmaceuticals.

Q

What sector and industry does Catabasis Pharmaceuticals (CATB) operate in?

A

Catabasis Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.